- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05843487
Association Between Carotid Plaque Length and Cardiovascular Outcomes
April 25, 2023 updated by: Changhai Hospital
This multicenter study involved 5 hospitals (Changhai Hospital; Yueyang Hospital of Shanghai University of Traditional Chinese Medicine; Gongli Hospital; Putuo Hospital of Shanghai University of Traditional Chinese Medicine; No. 904 Hospital of the PLA Joint Logistics Support Force Wuxi).
The study enrolled 5000 consecutive patients without known CAD who underwent first coronary angiography for stable chest pain and carotid ultrasound was performed during hospitalization from January 2017 through December 2018.
Study Overview
Status
Active, not recruiting
Conditions
Detailed Description
Patients who had obstructive CAD (defined as ≥50% luminal stenosis) confirmed by coronary angiography and who underwent carotid scanning were included in the final analysis.Carotid ultrasonography was performed simultaneously, and carotid intima-media thickness (IMT), maximum thickness and length of all plaques were measured.The incidence of major adverse cardiovascular events was recorded during follow-up.
Study Type
Observational
Enrollment (Anticipated)
3000
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Jiangsu
-
Wuxi, Jiangsu, China, 214000
- No. 904 Hospital of the PLA Joint Logistics Support Force
-
-
Shanghai
-
Shanghai, Shanghai, China, 200000
- Changhai Hospital
-
Shanghai, Shanghai, China, 200000
- Gongli Hospital
-
Shanghai, Shanghai, China, 200000
- Putuo Hospital
-
Shanghai, Shanghai, China, 200000
- Yueyang Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Sampling Method
Probability Sample
Study Population
Consecutive patients without known CAD who underwent first coronary angiography for stable chest pain and carotid ultrasound was performed during hospitalization.
Description
Inclusion Criteria:
- Patients who underwent coronary angiography for stable chest pain and carotid ultrasound simultaneously;
- Patients with obstructive CAD (≥50% coronary stenosis);
Exclusion Criteria:
- <18 years of age;
- previous carotid surgery or significant carotid artery disease;
- prior stroke or transient ischemic attack;
- previously documented CAD (including history of myocardial infarction, acute coronary syndrome, or coronary revascularization);
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
---|
Carotid plaque length
Patients underwent carotid ultrasonography and first coronary angiography simultaneously
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
major adverse cardiovascular events
Time Frame: 3 years
|
cardiovascular death, myocardial infarction, ischemic stroke and coronary revascularization
|
3 years
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
all-cause death
Time Frame: 3 years
|
3 years
|
cardiovascular death
Time Frame: 3 years
|
3 years
|
myocardial infarction
Time Frame: 3 years
|
3 years
|
ischemic stroke
Time Frame: 3 years
|
3 years
|
coronary artery revascularization
Time Frame: 3 years
|
3 years
|
heart failure
Time Frame: 3 years
|
3 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Pan Li, PhD, Changhai Hospital
- Study Director: Liang Chen, MD, No. 904 Hospital of the PLA Joint Logistics Support Force
- Study Director: Wei Zhang, MD, Gongli Hospital
- Study Director: Yawei Yang, MD, Yueyang Hospital
- Study Director: Jian Jian Na, MD, Putuo Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 1, 2017
Primary Completion (Actual)
March 31, 2022
Study Completion (Anticipated)
December 31, 2030
Study Registration Dates
First Submitted
April 25, 2023
First Submitted That Met QC Criteria
April 25, 2023
First Posted (Estimate)
May 4, 2023
Study Record Updates
Last Update Posted (Estimate)
May 4, 2023
Last Update Submitted That Met QC Criteria
April 25, 2023
Last Verified
June 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CPL
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Coronary Artery Disease
-
Elixir Medical CorporationIstituto Clinico HumanitasActive, not recruitingCoronary Artery Disease | Chronic Total Occlusion of Coronary Artery | Multi Vessel Coronary Artery Disease | Bifurcation of Coronary Artery | Long Lesions Coronary Artery DiseaseItaly
-
Fundación EPICActive, not recruitingCoronary Artery Disease | Left Main Coronary Artery Disease | Left Main Coronary Artery Stenosis | Restenosis, CoronarySpain
-
Peking Union Medical College HospitalRecruitingCoronary Artery Disease | Inflammation | Coronary Artery Disease Progression | Coronary Artery Stenosis | Coronary Artery Restenosis | Inflammatory Disease | Inflammation VascularChina
-
Peking Union Medical College HospitalNot yet recruitingCoronary Artery Disease | Inflammation | Coronary Artery Disease Progression | Coronary Artery Stenosis | Coronary Artery Restenosis | Inflammatory Disease | Inflammation VascularChina
-
IGLESIAS Juan FernandoUniversity of BernNot yet recruiting
-
National Institutes of Health Clinical Center (CC)National Heart, Lung, and Blood Institute (NHLBI)CompletedCoronary Arteriosclerosis | Coronary Artery Disease (CAD) | Obstructive Coronary Artery DiseaseUnited States
-
Barts & The London NHS TrustImperial College London; Brunel UniversityNot yet recruitingCORONARY ARTERY DISEASE
-
Abbott Medical DevicesCompletedCoronary Artery Disease | Coronary Disease | Coronary Occlusion | Chronic Total Occlusion of Coronary Artery | Coronary Restenosis | Coronary Artery Stenosis | Coronary Artery RestenosisBelgium
-
Fundación EPICRecruitingCoronary Artery Disease | Coronary Disease | Coronary Occlusion | Left Main Coronary Artery Disease | Coronary Artery StenosisSpain
-
San Luigi Gonzaga HospitalRecruitingCoronary Disease | STEMI | Coronary Artery Ectasia | Right Coronary Artery Occlusion | Right Coronary Artery StenosisSpain, Italy